Phacoemulsification Surgery in Patients with Cataract Formation After Intravitreal Injection of Triamcinolone Acetonide

被引:0
作者
Ozkiris, Abdullah [1 ]
Aksu, Recep [2 ]
Erkilic, Kuddusi [1 ]
Tuzcu, Esra Ayhan [1 ]
Ilhan, Ozgur [1 ]
机构
[1] Erciyes Univ, Med Fac, Dept Ophthalmol, Kayseri, Turkey
[2] Erciyes Univ, Med Fac, Dept Anesthesia, Kayseri, Turkey
关键词
Cataract; Intravitreal triamcinolone acetonide injection; Phacoemulsification;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To evaluate the results and complications of phacoemulsification surgery due to various factors in patients with cataract formation after intravitreal injection of triamcinolone acetonide (IVTA). Materials and Methods: Forty-five eyes of 32 patients with cataract formation that had developed after one or multiple IVTA injections wore included in the study. Among these patients, 28 eyes had diabetic macular edema, 7 eyes had branch retinal vein occlusion, 2 eyes had central retinal vein occlusion, 4 eyes had choroidal neovascular membrane due to age-related macular degeneration, 2 eyes had uveitic cystoid macular edema and 2 eyes had posterior uveitis. The mean age of the patients was 52.4 +/- 11.0 years, and all patients underwent standard phacoemulsification surgery with foldable intraocular lens implantation. Results: Minimal hemorrhage developed during surgery in 2 patients with diabetic retinopathy. After anterior chamber lavage, there was no hemorrhage after surgery and during the following days. Postoperatively, transient intraocular pressure elevation treated with topical antiglaucomatous medication was observed in 5 eyes. Seven eyes required Nd:YAG laser therapy due to posterior capsule opasification after a mean follow-up time of 8.5 months. Conclusion: There were no additional complications secondary to IVTA injection during or after phacoemulsification surgery in patients with cataract formation following IVTA injection.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 28 条
  • [1] Cataract after vitrectomy in young patients
    Blodi, BA
    Paluska, SA
    [J]. OPHTHALMOLOGY, 1997, 104 (07) : 1092 - 1095
  • [2] GLUCOCORTICOID LENS PROTEIN ADDUCTS IN EXPERIMENTALLY INDUCED STEROID CATARACTS
    BUCALA, R
    GALLATI, M
    MANABE, S
    COTLIER, E
    CERAMI, A
    [J]. EXPERIMENTAL EYE RESEARCH, 1985, 40 (06) : 853 - 863
  • [3] Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up
    Challa, JK
    Gillies, MC
    Penfold, PL
    Gyory, JF
    Hunyor, ABL
    Billson, FA
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1998, 26 (04): : 277 - 281
  • [4] Danis RP, 2000, RETINA-J RET VIT DIS, V20, P244, DOI 10.1097/00006982-200005000-00003
  • [5] Intravitreal triamcinolone for refractory diabetic macular edema - Two-year results of a double-masked, placebo-controlled, randomized clinical trial
    Gillies, Mark C.
    Sutter, Florian K. P.
    Simpson, Judy M.
    Larsson, Jorgen
    Ali, Haipha
    Zhu, Meidong
    [J]. OPHTHALMOLOGY, 2006, 113 (09) : 1533 - 1538
  • [6] A Randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration - One year results
    Gillies, MC
    Simpson, JM
    Luo, W
    Penfold, P
    Hunyor, ABL
    Chua, W
    Mitchell, P
    Billson, F
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (05) : 667 - 673
  • [7] Ip MS, 2002, ARCH OPHTHALMOL-CHIC, V120, P1217
  • [8] Ocular side effects and complications of intravitreal triamcinolone acetonide injection
    Jaissle, GB
    Szurman, P
    Bartz-Schmidt, KU
    [J]. OPHTHALMOLOGE, 2004, 101 (02): : 121 - 128
  • [9] Jonas JB, 2003, ARCH OPHTHALMOL-CHIC, V121, P57
  • [10] Cataract surgery after intravitreal injection of triamcinolone acetonide
    Jonas, JB
    Kreissig, I
    Degenring, RF
    [J]. EYE, 2004, 18 (04) : 361 - 364